# Remimazolam Consumption: TCI vs. Manual Infusion

> **NCT07377695** · NA · RECRUITING · sponsor: **Seoul National University Hospital** · enrollment: 58 (estimated)

## Conditions studied

- Moyamoya Disease

## Interventions

- **OTHER:** Target-Controlled Infusion (TCI) of Remimazolam
- **OTHER:** Manual Infusion of Remimazolam

## Key facts

- **NCT ID:** NCT07377695
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-04
- **Primary completion:** 2026-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07377695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07377695, "Remimazolam Consumption: TCI vs. Manual Infusion". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07377695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*